By Esha Dey (Reuters) - Imagine a weight-loss drug that not only helps you shed a few pounds, but does so without asking you to diet or exercise. In an industry dogged by safety concerns, a private U.S. company is betting on a new approach to deliver just such a treatment that could end up being the first billion-dollar diet drug. Initial trials show that Zafgen Inc, run by a former Novartis AG executive, might have an edge over its competitors, especially since its experimental drug has so far not demonstrated any major safety concerns. ...
via Health News Headlines - Yahoo! News http://news.yahoo.com/entrant-obesity-drug-race-targets-body-not-mind-134722900.html
via Health News Headlines - Yahoo! News http://news.yahoo.com/entrant-obesity-drug-race-targets-body-not-mind-134722900.html
No comments:
Post a Comment